drugset / Trial / NCT02373462
Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)
RandomizedParallel-groupOpen-labelTreatment
Summary
To study the effect of olmesartan on walking distance and quality of life in peripheral artery disease patients with hypertension treated For intermittent claudication.
Timeline
- Start
- 2015-08-25
- Primary completion
- 2015-11-17
- Completion
- 2015-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olmesartan | Other / unclassified | 40 mg | — |